Kolexia
Turlure Pascal Hématologie
Turlure Pascal
Hématologie
Hôpital Dupuytren
Limoges, France
231 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Maladie du greffon contre l'hôte Leucémie-lymphome lymphoblastique à précurseurs B et T Syndromes myélodysplasiques Lymphomes Maladie de Hodgkin Chromosome Philadelphie

Collaborateurs

Voir plus
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Dombret Herve
Dombret Herve
Hôpital Saint-Louis, Paris, France
Chantepie Sylvain
Chantepie Sylvain
Hôpital Côte de Nacre, Caen, France
Yakoub-Agha Ibrahim
Yakoub-Agha Ibrahim
Centre Hospitalier de Lille, Lille, France

Industries

Voir plus
Biotest
2 collaboration(s)
Dernière en 2023
MSD
1 collaboration(s)
Dernière en 2023
ENLIVEN THERAPEUTICS
1 collaboration(s)
Dernière en 2023
Parexel
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood   07 mars 2024
OGILAR: Open-label, Phase 2 Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia
Essai Clinique (French Innovative Leukemia Organisation)   05 février 2024
ALFA2101: An ALFA 2101 Multicenter Randomized Phase II Study: CPX-351 Versus Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
Essai Clinique (CHU Nice)   29 janvier 2024
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
Annals of hematology   26 janvier 2024
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
Journal of hematology & oncology   07 janvier 2024
Empirical Versus Preemptive Antifungal Therapy: Empirical Versus Pre-emptive (Diagnostic-driven) Antifungal Therapy of Patients Treated for Haematological Malignancies or Receiving an Allogeneic Stem Cell Transplant. A Therapeutic Open Label Phase III Strategy Study of the EORTC Infectious Diseases and Leukemia Groups
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   08 décembre 2023
Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Transplantation and cellular therapy   23 novembre 2023
HAPLO-EMPTY: Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression: a Nationwide Phase II Study
Essai Clinique (Assistance publique – Hôpitaux de Paris)   21 novembre 2023
FLUCLORIC: Randomized Multicentric Phase III Study Comparing the Efficacy of 2 Reduced Intensity Conditioning Regimens (Clofarabine/Busulfan vs Fludarabine/Busulfan) in Adults With AML and Eligible to Allogeneic Stem Cell Transplantation
Essai Clinique (CHU Nantes)   13 novembre 2023
Checkpoint Inhibitors and Allo-SCT in Hodgkin Lymphoma: A Matter of Time - a Study By the SFGM-TC
65th ASH Annual Meeting Abstracts   02 novembre 2023